Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®

Contributed by: Business Wire

Logo

Tags

Food Tech

Retail

FDA

Health

Technology

Food/Beverage

Onego Bio

More Like This

Onego Bio Submits Formal GRAS Notification to FDA for Bioalbumen®

Onego Bio and Sigma Foods Enter Collaboration to Strengthen Egg Protein Innovation and Supply Resilience

Onego Bio Launches “The Power of Trichoderma reesei” Series to Showcase Innovation, Scale, and Real-World Applications

Dr. Antti Vasara

Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

/DISREGARD RELEASE: Angel Yeast/

PR Newswire associated0

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9